Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?

Angelin, Martin (author): Umeå University,Umeå universitet,Infektionssjukdomar,Department of Clinical Microbiology, Infectious Diseases, Umeå University, Sweden,Umeå Univ, Dept Clin Microbiol, Infect Dis, Umeå, Sweden.

Sjölin, Jan (author): Uppsala University,Uppsala universitet,Infektionsmedicin

Kahn, Fredrik (author): Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Neutrofiler – nya mekanismer och nya markörer,Forskargrupper vid Lunds universitet,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Neutrophils – new mechanisms and new biomarkers,Lund University Research Groups

Ljunghill Hedberg, Anna (author): Uppsala University,Uppsala universitet,Infektionsmedicin

Rosdahl, Anja, 1972- (author): Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län,School of Medical Sciences, Örebro University, Örebro, Sweden; Department of Infectious Diseases, Örebro University Hospital, Örebro, Sweden,Örebro Univ, Sch Med Sci, Örebro, Sweden.;Örebro Univ Hosp, Dept Infect Dis, Örebro, Sweden.

Skorup, Paul (author): Uppsala University,Uppsala universitet,Infektionsmedicin

Werner, Simon (author): Department of Infectious Diseases, Skåne University Hospital, Region Skåne, Malmö, Sweden,Reg Skane, Skane Univ Hosp, Dept Infect Dis, Malmö, Sweden.

Woxenius, Susanne (author): Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden.

(creator_code:org_t)

Elsevier, 2023
2023
English.
In: Travel Medicine and Infectious Disease. - : Elsevier. - 1477-8939 .- 1873-0442. ; 54

Related links:: https://doi.org/10.1...; show more...; https://umu.diva-por... (primary) (Raw object); https://uu.diva-port... (primary) (Raw object); http://dx.doi.org/10... (free); https://urn.kb.se/re...; https://doi.org/10.1...; https://urn.kb.se/re...; https://urn.kb.se/re...; https://lup.lub.lu.s...; http://kipublication...; show less...

Abstract Subject headings

Qdenga® has been approved by the European Medicines Agency (EMA) for individuals > 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical studies on 4–16-year old's living in endemic areas. For individuals 16–60 years old only serological data exists and there is no data for individuals > 60 years. Its use as a travel vaccine is still unclear. We present the studies behind the approval and the recommendations for travelers as issued by the Swedish Society for Infectious Diseases Physicians.

By the author/editor: Angelin, Martin; Sjölin, Jan; Kahn, Fredrik; Ljunghill Hedber ...; Rosdahl, Anja, 1 ...; Skorup, Paul; show more...; Werner, Simon; Woxenius, Susann ...; Askling, Helena ...; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Infectious Medic ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Health Sciences; and Public Health Gl ...

By the university: Umeå University; Örebro University; Uppsala University; Lund University; Karolinska Institutet

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.